CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale President & CEO sold 450,000 shares at an average $19.93 ($8,966,931)
- 4 Open-market sale SVP, COO & CFO sold 150,000 shares at an average $19.86 ($2,979,629)
- 4 Open-market sale SVP & Chief Accounting Officer sold 75,000 shares at $18.62 ($1,396,500)
- 4 Exercise or conversion Director acquired 40,000 shares (option exercise)
- 4 Gift Director gave 51,500 shares (gift)
- 4 Grant or award Chief R&D Officer acquired 40,000 shares (grant or award)
- 4 Grant or award SVP & General Counsel acquired 28,550 shares (grant or award)
- 4 Grant or award SVP & Chief Accounting Officer acquired 16,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 106,650 shares (grant or award)
- 4 Grant or award SVP & Chief Commercial Officer acquired 28,550 shares (grant or award)
- 4 Grant or award SVP, COO & CFO acquired 40,000 shares (grant or award)
- 4 Open-market sale Director sold 1,560 shares at $17.82 ($27,799)
- 4 Open-market sale Chief R&D Officer sold 16,380 shares at $16.40 ($268,632)
- 4 Open-market sale Chief R&D Officer sold 29,618 shares at $16.93 ($501,433)
- 4 Open-market sale SVP & General Counsel sold 1,539 shares at $16.93 ($26,055)
- 4 Open-market sale SVP & Chief Accounting Officer sold 11,976 shares at $16.93 ($202,754)
- 4 Open-market sale President & CEO sold 11,975 shares at $16.93 ($202,737)
- 4 Open-market sale SVP, COO & CFO sold 8,276 shares at $16.93 ($140,113)
- 4 Open-market sale Director sold 3,250 shares at $17.25 ($56,063)
- 4 Open-market sale Director sold 5,500 shares at $17.75 ($97,625)
Page 10 of 49 · 970 filings